Dravet Syndrome Clinical Trial

Thank you for your interest in Lundbeck’s Dravet syndrome clinical trial. After careful consideration, Lundbeck has made the decision to discontinue clinical studies of clobazam in patients with Dravet syndrome. Importantly, the discontinuation of the studies is not related to any safety concerns with clobazam. If you have questions, please call (866) 402-8520. 

You are about to leave Lundbeck Clinical Trial Recuit website.